XML Financial »

Iovance Biotherapeutics shares owned by XML Financial

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by XML Financial from 13F filings

Historical chart of XML Financial investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by XML Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by XML Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $136k 15k 9.39
2024-06-30 $108k 14k 8.02
2024-03-31 $193k 13k 14.82

More positions owned by XML Financial

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Ishares Tr Core Div Grwth (DGRO)
Ishares Tr Rus 1000 Etf (IWB)
Microsoft Corporation (MSFT)
Ishares Tr Rus Mid Cap Etf (IWR)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
PIMCO Corporate Opportunity Fund (PTY)
Vanguard World Inf Tech Etf (VGT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr Ser Tr Bbg Conv Sec Etf (CWB)

View all positions for XML Financial

Top funds holding Iovance Biotherapeutics

Perceptive Advisors
Vanguard Group
MHR Fund Management
BlackRock
BlackRock
State Street Corporation
Soleus Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Artisan Partners Limited Partnership
Balyasny Asset Management
Long Focus Capital Management
Principal Financial Group
T. Rowe Price Associates
Palo Alto Investors

View all funds holding Iovance Biotherapeutics